- Trials with a EudraCT protocol (113)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
113 result(s) found for: SSRI.
Displaying page 1 of 6.
EudraCT Number: 2019-002232-82 | Sponsor Protocol Number: KIH18001 | Start Date*: 2019-07-25 |
Sponsor Name:Karolinska Institutet | ||
Full Title: Downstream targets of SSRI effect in treatment of Major Depressive Disorder | ||
Medical condition: Major depressive disorder (MDD) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-002735-32 | Sponsor Protocol Number: EB72 | Start Date*: 2008-06-24 |
Sponsor Name:Emotional Brain | ||
Full Title: A double blind, randomized, placebo controlled cross-over study to investigate the subjective and physiological efficacy and safety of Lybrido and Lybridos in the domestic setting in healthy female... | ||
Medical condition: Hypoactive sexual desire disorder and female sexual arousal disorder in combination with SSRI use. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2006-001317-15 | Sponsor Protocol Number: BAL2-2006 | Start Date*: 2006-05-09 |
Sponsor Name:University of Oxford | ||
Full Title: BALANCE 2: Bipolar disorder:Antidepressant/Lamotrigine/ANtipsychotic Comparative Evaluation | ||
Medical condition: Bipolar depression. | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2005-002430-34 | Sponsor Protocol Number: H9U-MC-MDBE | Start Date*: 2005-10-25 |
Sponsor Name:Eli Lilly & Company Limited | ||
Full Title: Effects of 5HT2A Blockade in Depressed Patients with Inadequate Antidepressant Treatment Response | ||
Medical condition: The aim of the study is to test augmentation of SSRI therapy with LY2422347 in patients who continue to manifest significant levels of depressive symptoms following an adequate treatment with an SS... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: HU (Completed) ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-016790-15 | Sponsor Protocol Number: EB78 | Start Date*: 2009-12-03 |
Sponsor Name:Emotional Brain | ||
Full Title: A double blind, randomized, cross-over placebo controlled study to investigate the subjective and physiological efficacy and safety of Lybrido and Lybridos in the domestic setting in healthy female... | ||
Medical condition: Hypoactive Sexual Desire Disorder (comorbidity with other sexual dysfunctions e.g Female Sexual Arousal Disorder (FSAD) is allowed) and/or SSRI induced sexual dysfunctioning. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-003435-40 | Sponsor Protocol Number: CTU 0095 | Start Date*: 2006-08-29 | |||||||||||
Sponsor Name:Department of Health | |||||||||||||
Full Title: A Randomised Controlled Trial to Investigate the effectiveness of the Healthy Sexual Functioning (HSF) Module and Selective Serotonin Reuptake Inhibitor (SSRI) Medication to treat Deviant Sexual Ar... | |||||||||||||
Medical condition: Deviant Sexual Arousal (sex offender) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-004984-11 | Sponsor Protocol Number: P150962J | Start Date*: 2018-07-06 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: "Study of maintenance of the efficacy and adverse effects of pharmacological treatments in sex offenders with paraphilia" ESPARA | |||||||||||||
Medical condition: Sexual offenders with paraphilia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000160-28 | Sponsor Protocol Number: MusicPlasticity | Start Date*: 2020-08-28 |
Sponsor Name:Medical University of Vienna | ||
Full Title: Investigation of SSRI induced neuroplastic changes in musicians using functional magnetic resonance imaging | ||
Medical condition: Focal dystonia in musicians | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2013-001966-40 | Sponsor Protocol Number: CD001 | Start Date*: 2014-01-27 | ||||||||||||||||
Sponsor Name:Companion Diagnostics BV | ||||||||||||||||||
Full Title: A double blind, randomized, placebo controlled, cross-over, Lybridos dose finding study to validate the predictive power of the diagnostic model for Lybrido and Lybridos efficacy and to identify an... | ||||||||||||||||||
Medical condition: Hypoactive Sexual Desire Disorder/SSRI-induced sexual dysfunction | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002992-33 | Sponsor Protocol Number: 54135419TRD3013 | Start Date*: 2020-08-04 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Randomized, Open-label, Rater-Blinded, Active-Controlled, International, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Flexibly Dosed Esketamine Nasal Spray Compared Wit... | |||||||||||||
Medical condition: Treatment-Resistant Major Depressive Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) CZ (Completed) PL (Completed) DE (Completed) HU (Completed) FR (Completed) BE (Completed) PT (Completed) BG (Completed) DK (Completed) AT (Completed) NO (Completed) FI (Completed) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-021216-41 | Sponsor Protocol Number: H9P-MC-LNBR(a) | Start Date*: 2011-01-24 | |||||||||||
Sponsor Name:Eli Lilly and Company | |||||||||||||
Full Title: A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients with Major Depressive Disorder Who Are Partial Responders... | |||||||||||||
Medical condition: Major depressive disorder (MDD) | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) GB (Completed) DE (Completed) AT (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-004509-29 | Sponsor Protocol Number: 2012-776 | Start Date*: 2015-11-03 | |||||||||||
Sponsor Name:Hospices Civils de Lyon | |||||||||||||
Full Title: Antidepressant treatments during pregnancy and lactation: prediction of drug exposure through breastfeeding and evaluation of drug effect on the neonatal adaptation and the development of the youn... | |||||||||||||
Medical condition: depression | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-020726-18 | Sponsor Protocol Number: H9P-MC-LNBO | Start Date*: 2011-01-17 | |||||||||||
Sponsor Name:Eli Lilly and Company | |||||||||||||
Full Title: Long-Term, Open-Label, Safety Study of LY2216684 12 to 18 mg Once Daily as Adjunctive Treatment for Patients with Major Depressive Disorder Who are Partial Responders to Selective Serotonin Reuptak... | |||||||||||||
Medical condition: Major depressive disorder (MDD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LT (Completed) NL (Completed) ES (Completed) PT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-000265-43 | Sponsor Protocol Number: München/CS04 | Start Date*: 2018-05-30 | |||||||||||
Sponsor Name:Max-Planck-Institut für Psychiatrie | |||||||||||||
Full Title: A randomized, placebo-controlled trial comparing the treatment effect of Pegvisomant and the SSRI Escitalopram on depressive acromegalic patients | |||||||||||||
Medical condition: Acromegalie with depression | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Temporarily Halted) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-021215-16 | Sponsor Protocol Number: H9P-MC-LNBQ | Start Date*: 2011-02-17 | |||||||||||
Sponsor Name:Eli Lilly and Company | |||||||||||||
Full Title: A Randomized, Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 mg to 18 mg Once Daily and LY2216684 Fixed-Dose 6 mg Once Daily as Adjunctive Treatment for Patients with Major De... | |||||||||||||
Medical condition: Major depressive disorder (MDD) | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) FI (Completed) SK (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-019423-61 | Sponsor Protocol Number: GENRAS | Start Date*: 2010-10-28 |
Sponsor Name:Medizinische Universität Wien,Univ.Klinik f.Psychiatrie und Psychotherapie | ||
Full Title: GENRAS (GENetics of Response to Agomelatine vs. EScitalopram) | ||
Medical condition: depressive disorder | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-002649-19 | Sponsor Protocol Number: 7043 | Start Date*: 2010-04-07 |
Sponsor Name:Tartu University Hospital Psychiatry Clinic | ||
Full Title: Investigation of genetic predictors of the response to SSRI treatment in patients with panic disorder | ||
Medical condition: panic disorder | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: EE (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-005860-69 | Sponsor Protocol Number: ODEN | Start Date*: 2021-05-10 |
Sponsor Name:University of Gothenburg | ||
Full Title: OSU6162 as add-on in SSRI/SNRI-resistant depression (ODEN): a double-blind, placebo-controlled evaluation of efficacy and safety. | ||
Medical condition: Depression | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2020-004291-18 | Sponsor Protocol Number: 54135419TRD4010 | Start Date*: 2021-04-08 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: Open-label Long-Term Extension Study for Participants With Treatment-Resistant Major Depressive Disorder Who are Continuing Esketamine Nasal Spray Treatment From Study 54135419TRD3013 | |||||||||||||
Medical condition: Treatment-Resistant Major Depressive Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) CZ (Completed) HU (Completed) PL (Completed) BG (Completed) FI (Completed) GR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-024632-42 | Sponsor Protocol Number: H9P-MC-LNBN | Start Date*: 2011-05-05 | |||||||||||
Sponsor Name:Eli Lilly and Company | |||||||||||||
Full Title: LY2216684 compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder | |||||||||||||
Medical condition: major depressive disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) SK (Completed) GR (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
• EEA CTAs: Date study was authorised to proceed
• Outside EU/EEA: Date study was submitted in EudraCT
• Outside EU/EEA: Date study was submitted in EudraCT
